Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones